PG Insider Trade: 40,841 Shares Sold; 6,852 Options Reported
Rhea-AI Filing Summary
Reporting person: Aguilar Moses Victor Javier, Chief Research, Development & Innovation Officer at Procter & Gamble Co (PG). Transactions on 09/15/2025: the Form 4 discloses a disposition of 40,841.1704 shares of P&G common stock and continuing indirect holdings of 6,750.7456 shares held by a Retirement Plan Trustee and 428.6033 shares held by an International Stock Ownership Plan (Mexico) Trustee. The filing also reports an acquisition (transaction code A) of 6,852 stock options tied to 6,852 underlying common shares with a stated conversion/exercise price of $156.83 and a listed price of $0; the options show exercisability beginning 09/15/2028 and expiration 09/14/2035. The form is signed by an attorney-in-fact on behalf of Mr. Aguilar on 09/17/2025.
Positive
- Reporting compliance: Form 4 was filed and signed, fulfilling Section 16 disclosure requirements
- Long-term option structure: Options reported have exercisability starting 09/15/2028, indicating long-dated vest/exercise timing
Negative
- Large disposition reported: A disposal of 40,841.1704 common shares was recorded on 09/15/2025
Insights
TL;DR: Routine insider Form 4 shows a sizable share disposition and a grant/acquisition of stock options with multi-year vest/exercise dates.
The filing documents a sale/disposition of 40,841.1704 common shares and reports indirect ownership via retirement and international plans totaling 7,179.3489 shares. It separately records an option transaction for 6,852 options tied to the same number of underlying shares at a stated conversion price of $156.83, exercisable from 09/15/2028 to 09/14/2035. For investors, the filing is a compliance disclosure of insider activity; it does not include company performance metrics or provide context for the insider's reasons for the disposition.
TL;DR: Disclosure aligns with Section 16 reporting; shows both disposal and an option acquisition subject to future exercisability.
The Form 4 is properly executed and signed by an attorney-in-fact, indicating timely reporting procedure. The mix of a direct disposition and indirect holdings via plan trustees is common for executive holders. The option transaction includes a multi-year exercise window beginning in 2028, suggesting long-term compensation timing rather than immediate equity transfer. The filing contains no indications of policy breaches or governance concerns based solely on the disclosed entries.